Novanta Inc
NASDAQ:NOVT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
149.41
186.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Novanta Inc
Novanta Inc
Net Issuance of Common Stock
Novanta Inc
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Novanta Inc
NASDAQ:NOVT
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Teledyne Technologies Inc
NYSE:TDY
|
Net Issuance of Common Stock
-$151.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-2%
|
|
|
Keysight Technologies Inc
NYSE:KEYS
|
Net Issuance of Common Stock
-$377m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
Badger Meter Inc
NYSE:BMI
|
Net Issuance of Common Stock
$751k
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-6%
|
|
|
Trimble Inc
NASDAQ:TRMB
|
Net Issuance of Common Stock
-$282.3m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-70%
|
|
|
Zebra Technologies Corp
NASDAQ:ZBRA
|
Net Issuance of Common Stock
-$16m
|
CAGR 3-Years
14%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Novanta Inc
Glance View
Nestled in the robust landscape of innovative technology solutions, Novanta Inc. stands as a pillar of precision and innovation. This Massachusetts-based company crafts its opportunities within the realm of advanced technology, specializing in photonics, vision, and precision motion technologies. Novanta’s journey is characterized by its adeptness in creating value through a blend of engineering prowess and strategic collaborations. Over time, Novanta has cultivated its niche by acquiring specialized companies that align with its mission, enabling it to leverage synergies across a vast landscape of industries including medical and industrial OEMs. By doing so, it meticulously aligns its product offerings with the intricate and evolving demands of global markets. The company's business model is a testament to its strategic direction—combining organic growth with tactical acquisitions that bolster its position in high-growth markets. Revenues are channeled through a diverse portfolio of highly engineered products and solutions, which incorporate lasers, photonics, and precision motion components. These technologies are paramount in sectors demanding extreme precision and reliability such as robotics, semiconductor equipment, and minimally invasive surgery. By focusing on innovation and maintaining a customer-centric approach, Novanta not only fortifies its competitive edge but also secures its reputation as a reliable partner in pushing the boundaries of what technology can achieve. This strategic alignment not only maximizes profitability but also ensures that Novanta remains at the forefront of technological advancement.
You don't have any saved screeners yet